Cutaneous Toxicities in Patients With Melanoma Receiving Checkpoint Inhibitor Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Cutaneous Toxicities in Patients With Melanoma Receiving Checkpoint Inhibitor Therapy: A Retrospective Review. The Experience of a Single Large Specialist Institution
Clin Exp Dermatol 2020 Oct 03;[EPub Ahead of Print], CL Edwards, F Comito, S Agraso Busto, C Harland, S Turajlic, J Larkin, K Heelan, L FearfieldFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.